← Open Payments lookup

LAUREL OWENS: Open Payments

NPI 1104073907 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$64,377 in 322 payments from 14 companies in 2025. Trend: 2023 $48,151 · 2024 $42,354 · 2025 $64,377

Speaker / faculty: $37,870Consulting: $12,275Travel & lodging: $10,156Food & beverage: $4,076
CompanyPaymentsAmount
Alkermes, Inc.111$45,166
ABBVIE INC.50$17,225
E.R. Squibb & Sons, L.L.C.44$414
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)31$390
Vanda Pharmaceuticals Inc.14$284
Teva Pharmaceuticals USA, Inc.21$213
Lundbeck LLC11$178
Otsuka America Pharmaceutical, Inc.20$165
Neurocrine BioSciences, Inc.6$123
Janssen Pharmaceuticals, Inc9$111

Products named: ARISTADA, LYBALVI, VRAYLAR, COBENFY, CAPLYTA, REXULTI, FANAPT, UZEDY.

Industry payments across MO — which companies pay providers there.